Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys

Journal of Neurochemistry

Volumn 80, Issue 1, 2002, Pages 168-177

  Gerhardt, Greg A ^a,b   Cass, Wayne A ^a   Yi, Ai ^a   Zhang, Zhiming ^a   Gash, Don M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Aging; Dopamine; Microdialysis; Putamen; Substantia nigra

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE DERIVATIVE; HOMOVANILLIC ACID; TYROSINE 3 MONOOXYGENASE;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL SIZE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; FEMALE; MICRODIALYSIS; MOTOR DYSFUNCTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RHESUS MONKEY; SENESCENCE; STEREOLOGY; SUBSTANTIA NIGRA;

AGING; ANIMALS; DENDRITES; DOPAMINE; FEMALE; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; MICRODIALYSIS; MOTOR ACTIVITY; NERVE ENDINGS; POSTMORTEM CHANGES; PUTAMEN; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; MACACA MULATTA;

EID: 0036270056     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-3042.2001.00684.x     Document Type: Article

References (59)

1. Age-correlated loss of dopamine uptake sites labeled with [3H] GBR-12935 in human putamen
2. Prevalence of parkinsonian signs and associated mortality in a community population of older people
3. Dopamine in dendrites of substantia nigra neurons: Suggestions for a role in dendritic terminal
4. Dopamine's reversal of fortune
5. Dendritic release of dopamine in the substantia nigra
6. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area and striamm
7. The regulation of motor control: An evaluation of the role of dopamine receptors in the substantia nigra
8. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys
9. Locomotion of aged rats: Relationship to neurochemical but not morphological changes in nigrostriatal dopaminergic neurons
10. Dendrodendritic inhibition through reversal of dopamine transport
11. Aging and Parkinson's disease: Substantia nigra regional selectivity
12. Neuron numbers and sizes in aging brain: Comparisons of human, monkey, and rodent data
13. Maintaining movement ability in old age: Challenges for gerontechnology
14. Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats
15. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys
16. Age-related changes in potassium-evoked overflow of dopamine in the striatum of the rhesus monkey
17. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
18. Estimating extracellular concentrations of dopamine and 3,4-dihydroxyphenylacetic acid in nucleus accumbens and striatum using microdialysis: Relationships between in vitro and in vivo recoveries
19. Rapid and sensitive determination of catecholamines in small tissue samples by high-pressure liquid chromatography coupled with dual-electrode coulometric electrochemical detection
20. Practical considerations for the use of the optical dissector in estimating neuronal number
21. Normal and drug-induced locomotor behavior in aging: Comparison to evoked DA release and tissue content in Fischer 344 rats
22. Age-related changes in the capacity, rate, and modulation of dopamine uptake within the striatum and nucleus accumbens of Fischer 344 rats: And in vivo electrochemical study
23. Age-related reductions in [3H] WIN 35,428 binding to the dopamine transporter in nigrostriatal and mesolimbic brain regions of the Fischer 344 rat
24. Functional effects of GDNF in normal rat striatum: Pre-synaptic studies using in vivo electrochemistry and microdialysis
25. Biochemistry of somatodendritic dopamine release in substantia niagra: An in vivo comparison with striatal dopamine release
26. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo
27. In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: Effects of locally applied uptake inhibitors and unilateral 6-OHDA lesions
28. Differences in the pharmacological properties of dopamine release between the substantia nigra and striatum: An in vivo electrochemical study
29. In vivo microdialysis studies of somatodendritic dopamine release in the rat substantia nigra: Effects of unilateral 6-OHDA lesions and GDNF
30. Die Topische Lokalisation und des verhaltan von noradrenalin and dopamine (3-hyrdoxytyramin) in der substantia nigra des normalen und parkinsonkranken menschen
31. Biochemical pathophysiology of Parkinson's disease
32. Aging and the basal ganglia
33. Aging and the nigrostriatal dopamine system: A non-human primate study
34. Aging produces a specific pattern of striatal dopamine loss: Implications for the etiology of idiopathic Parkinson's disease
35. Preservation of midbrain catecholaminergic neurons in very old human subjects
36. Pathogenesis of Parkinson's disease
37. Possible role of neuromelanin in the pathogenesis of Parkinson's disease
38. Age-related decline in striatal volume in monkeys as measure magnetic resonance imaging
39. Aging and extrapyramidal function
40. Differential effects of advancing age on neurotransmitter cell loss in the substantia nigra and striatum of C57BL/6N mice
41. Quantitative analysis of age-related dendritic changes in medium spiny I (MSI) striatal neurons of C57BL/6N mice
42. Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulata
43. Loss of D-2 receptor binding with age in rhesus monkeys: Importance of correction for differences in striatal size
44. Life and death of neurons in the aging brain
45. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons
46. Amphetamine-induced release of dopamine from the substantia nigra in vitro
47. A stereological study of substantia nigra in young and old rhesus monkeys
48. Dopamine DI receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata
49. Evidence that 1-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms
50. Anatomy of the dopamine system in the basal ganglia
51. Biochemical and anatomical changes in basal ganglia of aging animals
52. Stereological estimation of the total cell number of the human substantia nigra (pars compacta and pars reticulata)
53. Amphetamine-induced release of dendritic dopamine in substantia nigra pars reticulata: D1-mediated behavioral and electrophysiological effects
54. Parallel loss of pre-synaptic and post-synaptic dopamine markers in normal aging
55. New stereological methods for counting neurons
56. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
57. Unbiased stereological estimation of the number of neurons in the human hippocampus
58. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator
59. Motor slowing and parkinsonian signs in aging rhesus monkeys mirror human aging